RCSI led EU Consortium receives major funding to develop materials to regenerate cardiac tissue following heart attacks

摘要

The AMCARE (Advanced Materials for CArdiac REgeneration) consortium, which involves ten partners from five European countries, has received ?8.7 million in total funding (?6.8 million direct EU contribution) as part of the European Union's Framework Program 7, Nanosciences, nanotechnologies, materials and new production technologies. The AMCARE program will carry out research to develop natural materials and new surgical devices to enhance the delivery of the body's own stem cells to the heart to promote healing after a heart attack (myocardial infarction) and prevent premature death. The therapies being developed will replace heart cells that die due to the reduced blood flow that occurs during a heart attack, with new healthy cells derived from stem cells that come from the patient's own bone marrow.